nang kuang pharmaceutical (1752:Taiwan)

Financial Statements for nang kuang pharmaceutical (1752)

Currency in Millions of Taiwan Dollars	As of:	Dec 31 2009 TWD	Dec 31 2010 Restated TWD	Dec 31 2011 TWD	Dec 31 2012 TWD	4 Year Trend
Revenues		670.0	652.8	813.1	952.1
TOTAL REVENUES		670.0	652.8	813.1	952.1
Cost of Goods Sold		432.7	449.3	561.8	624.1
GROSS PROFIT		237.3	203.6	251.3	328.0
Selling General & Admin Expenses, Total		177.5	166.2	152.0	170.2
R&D Expenses		45.0	55.7	80.3	73.3
OTHER OPERATING EXPENSES, TOTAL		222.5	222.0	232.3	243.5
OPERATING INCOME		14.9	-18.4	19.0	84.5
Interest Expense		-5.4	-10.9	-13.9	-15.5
Interest and Investment Income		0.3	0.2	0.6	0.1
NET INTEREST EXPENSE		-5.1	-10.8	-13.3	-15.4
Currency Exchange Gains (Loss)		1.3	1.8	2.5	-2.6
Other Non-Operating Income (Expenses)		2.9	7.4	7.5	26.9
EBT, EXCLUDING UNUSUAL ITEMS		13.9	-20.0	15.6	93.4
Gain (Loss) on Sale of Investments		3.7	1.8	-4.0	0.9
Gain (Loss) on Sale of Assets		-0.1	-1.1	-0.4	-0.7
Other Unusual Items, Total		--	--	-0.5	--
Other Unusual Items		--	--	-0.5	--
EBT, INCLUDING UNUSUAL ITEMS		17.6	-19.2	10.8	93.6
Income Tax Expense		5.7	-8.7	4.7	13.2
Earnings from Continuing Operations		11.9	-10.6	6.2	80.4
NET INCOME		11.9	-10.6	6.2	80.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		11.9	-10.6	6.2	80.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		11.9	-10.6	6.2	80.4

Report Data Issue

To contact NANG KUANG PHARMACEUTICAL, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.